GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » Gross-Profit-to-Asset %

Shanghai Universal Biotech Co (SZSE:301166) Gross-Profit-to-Asset % : 8.40% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Universal Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shanghai Universal Biotech Co's annualized Gross Profit for the quarter that ended in Dec. 2024 was ¥193 Mil. Shanghai Universal Biotech Co's average Total Assets over the quarter that ended in Dec. 2024 was ¥2,302 Mil. Therefore, Shanghai Universal Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 8.40%.


Shanghai Universal Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shanghai Universal Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Universal Biotech Co Gross-Profit-to-Asset % Chart

Shanghai Universal Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.28 17.72 11.12 9.86 8.59

Shanghai Universal Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.11 8.80 9.02 8.37 8.40

Competitive Comparison of Shanghai Universal Biotech Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Shanghai Universal Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Universal Biotech Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Universal Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shanghai Universal Biotech Co's Gross-Profit-to-Asset % falls into.


;
;

Shanghai Universal Biotech Co Gross-Profit-to-Asset % Calculation

Shanghai Universal Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=201.847/( (2391.373+2309.42)/ 2 )
=201.847/2350.3965
=8.59 %

Shanghai Universal Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=193.488/( (2295.049+2309.42)/ 2 )
=193.488/2302.2345
=8.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Shanghai Universal Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shanghai Universal Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Universal Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1690 Kongjiang Road, Room 1505, Yangpu District, Shanghai, CHN, 200082
Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.
Executives
Leng Zhao Wen Director

Shanghai Universal Biotech Co Headlines

No Headlines